These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 9845942)

  • 1. [The effect of cerebrolysin intravenous injections in resistant forms of night enuresis in children].
    Gruzman AV; Levina IN
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(11):46. PubMed ID: 9845942
    [No Abstract]   [Full Text] [Related]  

  • 2. Cerebrolysin and its emerging clinical applications in psychiatry.
    Kapoor S
    Aust N Z J Psychiatry; 2013 Jul; 47(7):685. PubMed ID: 23405015
    [No Abstract]   [Full Text] [Related]  

  • 3. [The influence of cerebrolysin on the efficiency of subsequent therapy with amiridine++ in Alzheimer's disease patients (neuropsychological investigation)].
    Roshchina IF; Kolykhalov IV; Selezneva ND; Zharikov GA; Gerasimov NP; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(12):43-6. PubMed ID: 10629930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The experience with endolumbar application of cerebrolysin in hemispheric ischemic stroke].
    Vilenskiĭ BS; Odinak MM; Shirokov EA; Vozniuk IA; Semenova GM; Grinevich TV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(11):31-4. PubMed ID: 11247183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of cerebrolysin on the clinical symptoms and the course of ischemic encephalopathy].
    Chukanova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):42-5. PubMed ID: 15704482
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of cerebrolysin in the treatment of ischemic stroke].
    Koppi S; Barolin GS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(10):30-3. PubMed ID: 9819885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebrolysin alleviates perinatal CNS disorders through the autoimmune modulation and antioxidant protection].
    Serkina EV; Gromova OA; Torshin IIu; Sotnikova NIu; Nikonov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(11):62-6. PubMed ID: 19008804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Developmental dysphasia in children: perspectives of neurotrophic therapy].
    Zavadenko NN; Kozlova EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5 Pt 2):43-7. PubMed ID: 23739513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [4th International Symposium. "Cerebrolysin: pharmacological effects and role in clinical practice"].
    Gomazkov OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):69-70. PubMed ID: 12378888
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrophysiological correlates of efficacy of nootropic drugs in the treatment of consequences of traumatic brain injury in adolescents].
    Iznak EV; Iznak AF; Pankratova EA; Zavadenko NN; Guzilova LS; Guzilova IuI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):27-32. PubMed ID: 21322822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic results with Cerebrolysin in the treatment of dementia.
    Rainer M; Brunnbauer M; Dunky A; Ender F; Goldsteiner H; Holl O; Kotlan P; Paulitsch G; Reiner C; Stössl J; Zachhuber C; Mössler H
    Wien Med Wochenschr; 1997; 147(18):426-31. PubMed ID: 9408984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of cerebrolysin in the treatment of prolonged extrapyramidal complications of neuroleptic therapy].
    Kontsevoĭ VA; Medvedev AV; Andrusenko MP; Zvenigorodskaia IuV; Sheshenin VS
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(6):39-44. PubMed ID: 11517474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of cerebrolysin on the oxidant homeostasis, the content of microelements and electrolytes in children with minimal brain dysfunction].
    Gromova OA; Avdeenko TV; Burtsev EM; Skal'nyĭ AV; Solov'ev OI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(1):27-30. PubMed ID: 9505400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebrolysin and magnesium-B6 in the treatment of side effects of psychotropic drugs].
    Panteleeva GP; Bondar' VV; Krasnikova NI; Raiushkin VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(1):37-41. PubMed ID: 11530457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pathogenetical peculiarities and treatment policy in ischemic stroke of elderly and old age].
    Gafurov BG; Alikulova NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 11):44-6. PubMed ID: 15559220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perspectives on the treatment of organic mental disorders by the use of nootropic agents].
    Litvintsev SV; Shamreĭ VK; Reznik AM; Arbuzov AL
    Voen Med Zh; 2002 May; 323(5):59-62. PubMed ID: 12073844
    [No Abstract]   [Full Text] [Related]  

  • 17. Nocturnal polyuria is related to absent circadian rhythm of glomerular filtration rate.
    De Guchtenaere A; Vande Walle C; Van Sintjan P; Raes A; Donckerwolcke R; Van Laecke E; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2626-9. PubMed ID: 17945293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory nocturnal enuresis.
    Roberts JA
    Med J Aust; 1979 Sep; 2(6):313-4. PubMed ID: 574918
    [No Abstract]   [Full Text] [Related]  

  • 19. The evaluation of desmopressin in treatment of adolescent nocturnal enuresis.
    Derman O; Kanbur NO; Kinik E
    Int J Adolesc Med Health; 2004; 16(4):377-85. PubMed ID: 15712975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical and pharmacological model for explaining response to desmopressin.
    Nørgaard JP
    Scand J Urol Nephrol Suppl; 1999; 202():53-5. PubMed ID: 10573796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.